Parkside Financial Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $602K | Sell |
1,224
-158
| -11% | -$85.7K | 0.05% | 232 |
|
|
2025
Q4 | $801K | Buy |
1,382
+92
| +7% | +$52K | 0.06% | 180 |
|
|
2025
Q3 | $626K | Buy |
1,290
+312
| +32% | +$145K | 0.05% | 219 |
|
|
2025
Q2 | $397K | Sell |
978
-195
| -17% | -$81.5K | 0.04% | 287 |
|
|
2025
Q1 | $584K | Buy |
1,173
+134
| +13% | +$72.6K | 0.07% | 195 |
|
|
2024
Q4 | $541K | Sell |
1,039
-27
| -3% | -$14.8K | 0.07% | 194 |
|
|
2024
Q3 | $659K | Sell |
1,066
-3
| -0.3% | -$1.78K | 0.09% | 163 |
|
|
2024
Q2 | $591K | Buy |
1,069
+57
| +6% | +$32.7K | 0.09% | 165 |
|
|
2024
Q1 | $588K | Buy |
1,012
+127
| +14% | +$71.3K | 0.09% | 167 |
|
|
2023
Q4 | $470K | Sell |
885
-122
| -12% | -$59.1K | 0.09% | 178 |
|
|
2023
Q3 | $510K | Buy |
1,007
+13
| +1% | +$6.93K | 0.12% | 134 |
|
|
2023
Q2 | $519K | Sell |
994
-35
| -3% | -$18.9K | 0.12% | 133 |
|
|
2023
Q1 | $593K | Buy |
1,029
+37
| +4% | +$20.9K | 0.16% | 110 |
|
|
2022
Q4 | $546K | Buy |
992
+106
| +12% | +$56.2K | 0.16% | 113 |
|
|
2022
Q3 | $450K | Buy |
886
+7
| +0.8% | +$3.92K | 0.14% | 119 |
|
|
2022
Q2 | $478K | Sell |
879
-52
| -6% | -$28.6K | 0.15% | 121 |
|
|
2022
Q1 | $549K | Sell |
931
-121
| -12% | -$69.5K | 0.15% | 104 |
|
|
2021
Q4 | $702K | Buy |
1,052
+468
| +80% | +$292K | 0.17% | 91 |
|
|
2021
Q3 | $333K | Buy |
584
+34
| +6% | +$18.7K | 0.1% | 144 |
|
|
2021
Q2 | $277K | Buy |
550
+41
| +8% | +$19.3K | 0.08% | 163 |
|
|
2021
Q1 | $233K | Buy |
509
+9
| +2% | +$4.3K | 0.07% | 178 |
|
|
2020
Q4 | $233K | Buy |
500
+9
| +2% | +$4.22K | 0.07% | 174 |
|
|
2020
Q3 | $217K | Sell |
491
-74
| -13% | -$30.6K | 0.08% | 171 |
|
|
2020
Q2 | $204K | Buy |
565
+7
| +1% | +$2.35K | 0.07% | 198 |
|
|
2020
Q1 | $159K | Buy |
558
+63
| +13% | +$19.9K | 0.06% | 195 |
|
|
2019
Q4 | $161K | Buy |
495
+15
| +3% | +$4.55K | 0.05% | 214 |
|
|
2019
Q3 | $140K | Sell |
480
-28
| -6% | -$8.02K | 0.05% | 222 |
|
|
2019
Q2 | $150K | Buy |
508
+2
| +0.4% | +$551 | 0.05% | 216 |
|
|
2019
Q1 | $139K | Sell |
506
-13
| -3% | -$3.23K | 0.05% | 216 |
|
|
2018
Q4 | $116K | Buy |
519
+155
| +43% | +$36.4K | 0.04% | 229 |
|
|
2018
Q3 | $89K | Buy |
364
+68
| +23% | +$15.6K | 0.03% | 275 |
|
|
2018
Q2 | $61K | Buy |
296
+20
| +7% | +$4.25K | 0.02% | 318 |
|
|
2018
Q1 | $57K | Buy |
276
+11
| +4% | +$2.31K | 0.02% | 320 |
|
|
2017
Q4 | $50K | Sell |
265
-23
| -8% | -$4.41K | 0.02% | 361 |
|
|
2017
Q3 | $54K | Buy |
288
+41
| +17% | +$7.42K | 0.02% | 332 |
|
|
2017
Q2 | $43K | Sell |
247
-150
| -38% | -$25.2K | 0.02% | 364 |
|
|
2017
Q1 | $61K | Buy |
397
+185
| +87% | +$28.3K | 0.03% | 295 |
|
|
2016
Q4 | $30K | Sell |
212
-171
| -45% | -$25.2K | 0.01% | 438 |
|
|
2016
Q3 | $61K | Sell |
383
-12
| -3% | -$1.85K | 0.03% | 318 |
|
|
2016
Q2 | $58K | Sell |
395
-8
| -2% | -$1.18K | 0.03% | 316 |
|
|
2016
Q1 | $57K | Buy |
403
+42
| +12% | +$5.63K | 0.03% | 307 |
|
|
2015
Q4 | $51K | Sell |
361
-140
| -28% | -$18.7K | 0.03% | 321 |
|
|
2015
Q3 | $62K | Sell |
501
-13,048
| -96% | -$1.7M | 0.04% | 272 |
|
|
2015
Q2 | $1.76M | Sell |
13,549
-71
| -0.5% | -$9.26K | 0.93% | 22 |
|
|
2015
Q1 | $1.83M | Buy |
13,620
+187
| +1% | +$24.1K | 0.98% | 22 |
|
|
2014
Q4 | $1.68M | Buy |
13,433
+25
| +0.2% | +$3.04K | 0.95% | 21 |
|
|
2014
Q3 | $1.63M | Sell |
13,408
-91
| -0.7% | -$11.1K | 0.99% | 24 |
|
|
2014
Q2 | $1.59M | Buy |
13,499
+162
| +1% | +$19.1K | 0.95% | 26 |
|
|
2014
Q1 | $1.6M | Buy |
+13,337
| New | +$1.59M | 1% | 25 |
|
Other funds holding TMO
VCM
Parkside Financial Bank & Trust's TMO Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, selling an estimated $85.7K and leaving 1,224 shares worth $602K. The position accounts for 0.05% of the portfolio, ranked #232.
Parkside Financial Bank & Trust first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.83M in Q1 2015. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Parkside Financial Bank & Trust held 1,224 shares of Thermo Fisher Scientific worth $602K as of Q1 2026.
- Parkside Financial Bank & Trust sold 158 Thermo Fisher Scientific shares in Q1 2026, an estimated $85.7K.
- Thermo Fisher Scientific made up 0.05% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #232 holding.
- Parkside Financial Bank & Trust first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
- Parkside Financial Bank & Trust's Thermo Fisher Scientific position peaked at $1.83M in Q1 2015.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.